Skip to main content
Clinical Trials/NCT02373059
NCT02373059
Completed
Not Applicable

Examining the Use of a Shared Decision Making Tool With Pharmaceutical Care in Type 2 Diabetes

Mayo Clinic1 site in 1 country15 target enrollmentFebruary 2015
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
Mayo Clinic
Enrollment
15
Locations
1
Primary Endpoint
Patient Involvement Questionnaire
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

A research study to enhance clinical discussion between patients and pharmacists using a shared decision making tool for type 2 diabetes or usual care.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
June 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joseph R. Herges, Pharm.D., R.Ph.

Doctor of Pharmacy

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Adults ≥ 18 years of age
  • Diagnosed with type II diabetes by ICD-9 code for more than one year
  • HbA1c of 7%-9.5% within past 6 months
  • Prescribed three or less anti-hyperglycemic medications as indicated by the medication list within the medical record

Exclusion Criteria

  • Prescribed insulin
  • Pregnancy
  • Appointment with provider within a month
  • Appointment with provider within the last month
  • Followed by endocrinology

Outcomes

Primary Outcomes

Patient Involvement Questionnaire

Time Frame: Post-Visit up to 2 weeks

Secondary Outcomes

  • Patient Medication Adherence Questionnaire(1 month post visit)
  • Patient Knowledge regarding Diabetes treatments Questionnaire(post visit up to 2 weeks)

Study Sites (1)

Loading locations...

Similar Trials